Tower Research Capital (TRC) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$487M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$48.2M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$29.4M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$28.9M |
| 5 |
Microsoft
MSFT
|
+$27.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$51.8M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$38.5M |
| 3 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$32.6M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$21M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$16.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.25% |
| 2 | Industrials | 4.6% |
| 3 | Consumer Discretionary | 4.31% |
| 4 | Healthcare | 4.26% |
| 5 | Financials | 3.82% |
Similar funds
Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review
As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.
- Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
- Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
- Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
- Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
- Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
- Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
- Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.